As of today (2024-05-17), Recordati SpA's share price is €50.40.
Recordati SpA's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 was €0.73. Hence, Recordati SpA's Price-to-Free-Cash-Flow Ratio for today is 68.66.
The historical rank and industry rank for Recordati SpA's Price-to-Free-Cash-Flow or its related term are showing as below:
FRA:RER1'
s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 14.56 Med: 25.35 Max: 370.87
Current: 70.57
During the past 13 years, Recordati SpA's highest Price-to-Free-Cash-Flow Ratio was 370.87. The lowest was 14.56. And the median was 25.35.
FRA:RER1's Price-to-Free-Cash-Flow is ranked worse than 83.2% of 506
companies
in the Drug Manufacturers industry
Industry Median: 23.41
vs FRA:RER1: 70.57
During the past 12 months, the average Free Cash Flow per Share Growth Rate of Recordati SpA was -72.10% per year.
During the past 3 years, the average Free Cash Flow per Share Growth Rate was -27.90% per year.
During the past 13 years, Recordati SpA's highest 3-Year average Free Cash Flow per Share Growth Rate was 76.50% per year. The lowest was -27.90% per year. And the median was 13.15% per year.
Recordati SpA Price-to-Free-Cash-Flow Historical Data
The historical data trend for Recordati SpA's Price-to-Free-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Recordati SpA's Price-to-Free-Cash-Flow
For the Drug Manufacturers - General subindustry, Recordati SpA's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Recordati SpA's Price-to-Free-Cash-Flow Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Recordati SpA's Price-to-Free-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Recordati SpA's Price-to-Free-Cash-Flow falls into.
Recordati SpA Price-to-Free-Cash-Flow Calculation
Recordati SpA's Price-to-Free-Cash-Flow ratio for today is calculated as
Recordati SpA's Share Price of today is €50.40. Recordati SpA's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.73.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.
In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.
Be Aware
In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.
Recordati SpA Price-to-Free-Cash-Flow Related Terms
Thank you for viewing the detailed overview of Recordati SpA's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.
Recordati SpA is a drug manufacturing company that focuses on specialty pharmaceuticals. The company produces and promotes medicines globally that focus on primary-care therapies and rare diseases. Recordati uses strategic partnerships as part of its long-term growth. The vast majority of the company's revenue is generated in Italy, followed by the United States, France, and Germany. Recordati reports two operating segments: Specialty and Primary care and Rare diseases. The bulk of the company's profit is derived from its specialty and primary care segment, which includes the production of active ingredients.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
FRA:RER1 has been successfully added to your 